Home hover Guidelines hover Expert hover Compare hover Faq hover Submit hover About hover Resources hover Syntheses hover Myngc hover Guidelinematrix hover
Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
Search within:  

Sort results by:      



Filter results by:

1-20 of 75   Next >
 
1.  
Adjuvant interferon for malignant melanoma. 2014 Feb. NGC:010377
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
2.  
3.  
Management of in-transit disease of the limbs. 2010 May (revised 2013 Feb). NGC:010259
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
4.  
Guidelines on penile curvature. 2012 Feb. NGC:009149
European Association of Urology - Medical Specialty Society. View all guidelines by the developer(s)
5.  
Genital warts. In: Sexually transmitted diseases treatment guidelines, 2010. 1993 (revised 2010 Dec 17). NGC:008240
Centers for Disease Control and Prevention - Federal Government Agency [U.S.]. View all guidelines by the developer(s)
6.  
7.  
KDIGO clinical practice guideline for glomerulonephritis. 2012 Jun. NGC:009271
Kidney Disease: Improving Global Outcomes - Nonprofit Organization. View all guidelines by the developer(s)
8.  
Management of hepatitis C. A national clinical guideline. 2006 Dec (revised 2013 Jul). NGC:009981
Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
9.  
Leptomeningeal metastases. 2006 Jan (reaffirmed 2010). NGC:006064
Comprehensive Cancer Centre the Netherlands - Disease Specific Society. View all guidelines by the developer(s)
10.  
Referral and follow-up surveillance of cutaneous melanoma. 2011 Feb (revised 2013 Feb). NGC:010266
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
11.  
Recommendations for drug therapies for relapsing-remitting multiple sclerosis. 2013 Oct. NGC:010418
Canadian Agency for Drugs and Technologies in Health - Nonprofit Organization. View all guidelines by the developer(s)
12.  
Revised U.K. guidelines for the management of cutaneous melanoma 2010. 2002 Jan (revised 2010 Aug). NGC:008096
British Association of Dermatologists - Medical Specialty Society. View all guidelines by the developer(s)
13.  
Infectious diseases. 2013 Jun 28. NGC:010128
Work Loss Data Institute - For Profit Organization. View all guidelines by the developer(s)
14.  
15.  
Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection: United States 2010. 2003 Jan 31 (revised 2010 Jun 25). NGC:007953
Centers for Disease Control and Prevention - Federal Government Agency [U.S.]. View all guidelines by the developer(s)
16.  
Adjuvant radiation for malignant melanoma. 2012 Mar. NGC:009386
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
17.  
Telaprevir for the treatment of genotype 1 chronic hepatitis C. 2012 Apr. NGC:009076
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
18.  
Fingolimod for the treatment of highly active relapsing-remitting multiple sclerosis. 2012 Apr. NGC:009075
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
19.  
Hepatitis C virus. 2003 (revised 2010 May). NGC:008031
New York State Department of Health - State/Local Government Agency [U.S.]. View all guidelines by the developer(s)
20.  
Management of resectable stage IV primary cutaneous melanoma without nodal disease. 2010 May (revised 2013 Feb). NGC:010260
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
1-20 of 75   Next >